DE69515645D1 - Cd69 - transkriptionsregulierende elemente - Google Patents

Cd69 - transkriptionsregulierende elemente

Info

Publication number
DE69515645D1
DE69515645D1 DE69515645T DE69515645T DE69515645D1 DE 69515645 D1 DE69515645 D1 DE 69515645D1 DE 69515645 T DE69515645 T DE 69515645T DE 69515645 T DE69515645 T DE 69515645T DE 69515645 D1 DE69515645 D1 DE 69515645D1
Authority
DE
Germany
Prior art keywords
pct
date
transcription regulating
regulating elements
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69515645T
Other languages
English (en)
Other versions
DE69515645T2 (de
Inventor
L Feldhaus
F Ziegler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Ampliphi Biosciences Corp
Original Assignee
Immunex Corp
Targeted Genetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp, Targeted Genetics Corp filed Critical Immunex Corp
Publication of DE69515645D1 publication Critical patent/DE69515645D1/de
Application granted granted Critical
Publication of DE69515645T2 publication Critical patent/DE69515645T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056Lectin superfamily, e.g. CD23, CD72
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/15Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/60Vector systems having a special element relevant for transcription from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian
DE69515645T 1994-01-28 1995-01-20 Cd69 - transkriptionsregulierende elemente Expired - Fee Related DE69515645T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18843394A 1994-01-28 1994-01-28
PCT/US1995/000837 WO1995020670A1 (en) 1994-01-28 1995-01-20 Cd 69 transcriptional regulatory elements

Publications (2)

Publication Number Publication Date
DE69515645D1 true DE69515645D1 (de) 2000-04-20
DE69515645T2 DE69515645T2 (de) 2000-09-21

Family

ID=22693125

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69515645T Expired - Fee Related DE69515645T2 (de) 1994-01-28 1995-01-20 Cd69 - transkriptionsregulierende elemente

Country Status (8)

Country Link
US (1) US5759805A (de)
EP (1) EP0741791B1 (de)
AT (1) ATE190663T1 (de)
AU (1) AU682253B2 (de)
CA (1) CA2182116C (de)
DE (1) DE69515645T2 (de)
DK (1) DK0741791T3 (de)
WO (1) WO1995020670A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US20030069173A1 (en) * 1998-03-16 2003-04-10 Life Technologies, Inc. Peptide-enhanced transfections
US6051429A (en) * 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
DE19545351C1 (de) * 1995-12-05 1997-07-31 Univ Ludwigs Albert Eukaryotische Zellen mit Hybridrezeptor und dadurch steuerbarem Genkonstrukt, Verfahren zu deren Herstellung und Verwendung dieser Zellen in der Gentherapie
AU772847B2 (en) * 1998-11-12 2004-05-06 Invitrogen Corporation Transfection reagents
EP3169310A1 (de) 2014-07-15 2017-05-24 Life Technologies Corporation Zusammensetzungen mit lipidaggregaten und verfahren zur effizienten bereitstellung von molekülen an zellen
CN104195155A (zh) * 2014-08-05 2014-12-10 浙江大学 一种转基因小鼠动物模型的构建方法
WO2020243134A1 (en) 2019-05-27 2020-12-03 Immatics US, Inc. Viral vectors and their use in adoptive cellular therapy

Also Published As

Publication number Publication date
EP0741791B1 (de) 2000-03-15
DK0741791T3 (da) 2000-06-05
US5759805A (en) 1998-06-02
EP0741791A1 (de) 1996-11-13
CA2182116C (en) 2007-03-20
AU682253B2 (en) 1997-09-25
AU1686895A (en) 1995-08-15
CA2182116A1 (en) 1995-08-03
DE69515645T2 (de) 2000-09-21
ATE190663T1 (de) 2000-04-15
WO1995020670A1 (en) 1995-08-03

Similar Documents

Publication Publication Date Title
BG103886A (en) Regulation of the expression of quinolate phospho- ribosyltransferase
DE69434447D1 (de) Für die gentherapie verwendbare plasmide
MX9705039A (es) Genes y proteinas de muerte celular programada.
EP1143004A3 (de) Gegen Nematode aktive Bacillus thuringiensis-Mikroben, und Gene kodierend für Nematode-aktive Toxine kloniert von Bacillus thuringiensis-Stämmen
DE69434663D1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
DE69534618D1 (de) Verfahren zur herstellung rekombinanter adeno-associated viren (aav) und deren verwendung
AU8143994A (en) Cck-2, a receptor tyrosine kinase
DE69532283D1 (de) EIN PILZ, IN DEM DAS areA-GEN VERÄNDERT IST, UND EIN areA-GEN AUS ASPERGILLUS ORYZAE
NO950534D0 (no) Modufiserte soppceller og fremgangsmåter for fremstilling av rekombinante produkter
DE69326776T2 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE69533794D1 (de) Für eine cinnamoyl-coa-reduktase kodierende dna-sequenzen, und ihre verwendung in regulation des lignin-gehalts von pflanzen
DE69515645T2 (de) Cd69 - transkriptionsregulierende elemente
DK0651784T3 (da) Gærstammer, der udtrykker LDH-genet af mælk og vektorer, som kan anvendes til opnåelse af de nævnte stammer
DE69333953D1 (de) Promotor des transaldolase-genes von k.lactis und dessen verwendung
CA2139430A1 (fr) Polypeptides ayant une activite de recepteur serotoninergique (5ht5a), acides nucleiques codant pour ces polypeptides et utilisations
PT648836E (pt) Transactivador do mhc de classe ii (ciita) e suas utilizacoes
ZA933493B (en) Calcium channel blocking polypeptides from filistata hibernalis.
FI962047A0 (fi) Endoteliiniä muuntava entsyymi
WO2003080105A3 (fr) Genes regulateurs de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
DE69531678D1 (de) Rekombinatie viren,ihre herstellung und ihre verwendung in der gentherapie
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
DE69519654T2 (de) htFIIIA Gen
MX9707549A (es) Vectores virales y su uso para tratar trastornos hiperproliferativos, en particular restenosis.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee